195 related articles for article (PubMed ID: 16312308)
1. Comparative efficacy of amoxycillin + clavulanic acid (augmentin), flucloxacillin and vancomycin against S. aureus endocarditis in the rat.
Catherall EJ; Irwin R; Mizen L
J Chemother; 1989 Jul; 1(4 Suppl):69-70. PubMed ID: 16312308
[No Abstract] [Full Text] [Related]
2. Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
Catherall EJ; Irwin R; Mizen LW
J Antimicrob Chemother; 1991 Jan; 27(1):117-26. PubMed ID: 2050588
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of amoxycillin/clavulanate (Augmentin) in the treatment of severe staphylococcal infections.
Moreillon P
J Chemother; 1994 Apr; 6 Suppl 2():51-7. PubMed ID: 7799055
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
5. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Olay T; Vicente MV; Rodríguez A
J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
[No Abstract] [Full Text] [Related]
6. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcal osteomyelitis--a comparison of co-amoxiclav with clindamycin and flucloxacillin in an experimental rat model.
Gisby J; Beale AS; Bryant JE; Toseland CD
J Antimicrob Chemother; 1994 Nov; 34(5):755-64. PubMed ID: 7706171
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Staphylococcus aureus prosthetic valve endocarditis.
Hassoun A
Am J Med; 2007 Mar; 120(3):e9; author reply e11. PubMed ID: 17349434
[No Abstract] [Full Text] [Related]
10. The role of vancomycin in the treatment paradigm.
Stevens DL
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
[TBL] [Abstract][Full Text] [Related]
11. Short-course combination and oral therapies of Staphylococcus aureus endocarditis.
Chambers HF
Infect Dis Clin North Am; 1993 Mar; 7(1):69-80. PubMed ID: 8463654
[TBL] [Abstract][Full Text] [Related]
12. Experimental studies of amoxycillin-flucloxacillin combination.
Ripa S; Prenna M; Vitali C
Antibiotica; 1974 Jun; 12(2):88-106. PubMed ID: 4470369
[No Abstract] [Full Text] [Related]
13. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.
Cosgrove SE; Vigliani GA; Fowler VG; Abrutyn E; Corey GR; Levine DP; Rupp ME; Chambers HF; Karchmer AW; Boucher HW
Clin Infect Dis; 2009 Mar; 48(6):713-21. PubMed ID: 19207079
[TBL] [Abstract][Full Text] [Related]
14. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of cloxacillin and vancomycin against methicillin-susceptible Staphylococcus aureus experimental endocarditis.
Fernández Guerrero ML; de Górgolas M
J Antimicrob Chemother; 2006 Nov; 58(5):1066-9. PubMed ID: 16931540
[TBL] [Abstract][Full Text] [Related]
16. Therapy for methicillin-resistant Staphylococcus aureus.
Torres-Tortosa M; Caballero-Granado FJ; Canueto J
N Engl J Med; 2006 Nov; 355(20):2153-4; author reply 2155. PubMed ID: 17120350
[No Abstract] [Full Text] [Related]
17. New agents for Staphylococcus aureus endocarditis.
Drees M; Boucher H
Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.
Catherall EJ; Gillon V; Hurn S; Irwin R; Mizen L
Antimicrob Agents Chemother; 1992 Feb; 36(2):458-62. PubMed ID: 1605610
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of clavulanate-potentiated amoxycillin in pigeons (Columba livia).
Cooper JE
Res Vet Sci; 1985 Jul; 39(1):87-9. PubMed ID: 4035095
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
Miller WR; Singh KV; Arias CA; Murray BE
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
